The Latest Breaking News from Pandemic

The United Nations Environment Programme recently published a scientific review that looks at environmental threats and risks in light of the COVID pandemic. It analyses links between human infectious diseases and nature and what we know about how diseases (zoonoses) can transfer from animals to humans.

In The Light We Carry, the follow-up to her bestseller Becoming, the former first lady reveals her ‘fearful mind’ and experience of depression during the pandemic

At present just 61.7% of people get cancer treatment within 62 days, compared with 77.2% before the pandemic.

Frontier Airlines and four foreign carriers are paying more than $600 million in refunds to consumers whose flights were canceled or significantly delayed since the start of the pandemic

Although many university students are eager for in-person elements of the university experience they missed early in the pandemic, what might we overlook in the rush to “return to normal”?

WASHINGTON — Dr. Anthony Fauci knew he was being turned into a villain of the far-right early on in the coronavirus pandemic, when President Donald Trump’s administration stopped defending him.

A long-dreaded nightmare might be coming true for the housing sector.

The U.S. flu season is already off to a fast start as children return to schools, less mask-wearing and travel returns to COVID-19 pre-pandemic norms.

Student-run Nightline says growing numbers are seeking help for anxiety, depression and suicidal thoughts

Nearly three years into the COVID-19 pandemic, leaders of G20 countries are gathering on the Indonesian resort island of Bali with strict testing and masking requirements, even though such measures have been largely dropped in some member countries.

Gilead Sciences’ (GILD) popular covid product Veklury (Remdisivir) witnessed declining sales in the post-pandemic era. However, the company’s top line, excluding Veklury, has seen steady growth. Moreover, despite ongoing market volatility, the stock has registered stable gains. So, let’s find out if GILD is still a buy in the post-covid…